We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Low-Cost Technique Detects Rotavirus

By LabMedica International staff writers
Posted on 22 Oct 2014
A new measurement method that increases the capacity to detect biological substances such as Rotavirus using optical biosensors has been discovered and patented. More...


The system will enhance the detection capacity of small concentrations of Rotavirus due to a new way to assess the biosensing response applied to an interferometric device allowing the detection of both the presence of the virus and its antibody.

Scientists at the Universidad Politécnica de Madrid (Spain) have focused their interests on label-free optical biosensors that do not require the presence of enzymes that fix either the substance to be detected or the marker responsible for any detectable physical phenomenon. These biosensors consist of smooth or micro-nano textured surfaces made with a polymer whose surface has been chemically treated to be similar to a bioreceptor.

Once the surface is coated by the bioreceptor, the biosensor is sensitive and selective to a determined type of biomolecule. When the substance to detect is recognized by a bioreceptor this substance produces a change on its optical response or transduction. This change is usually the movement of the maximum or minimum position of the interferometric pattern. An easy interferometric system based on two Fabry Perot interferometers was tested. One interferometer is used as a reference and the other one captures the substance or virus. Besides, different options of data are analyzed as an alternative to the traditional position shift of the endpoints. This system is easy to install in compact devices and can be used by non-expert users.

The investigators have proved that by using transduction as a variable, the variation of emitted overall intensity at intervals of specific wave length, the sensitivity and detection limit of these biosensors can be significantly improved. All this can reach truly competitive levels for such a simple design. By using the proposed device and reading procedure, they could detect the presence of anti-Rotavirus in blood plasma or anti-Rotavirus as water contaminant. Due to its low cost compared to other methods such as enzyme-linked immunosorbent assay, this technique constitutes a promising way to reduce child mortality in developing countries.

Related Links:

Universidad Politécnica de Madrid



New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PlGF Test
Quidel Triage PlGF Test
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.